About Benjamin Potter
Form D filings for CuraSen Therapeutics from 2019 to 2024 list Benjamin Potter as executive officer.
Benjamin Potter first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Benjamin Potter in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Benjamin Potter works with at each company, as listed on that company's latest Form D.
CuraSen Therapeutics, Inc. · Form D, Sep 18, 2024
RH
Ron Hunt
Director
AF
Anthony Ford
President and Chief Executive Officer, director
LD
Loretta Tse, Ph.D.
Director
KG
Kathleen Glaub
Director
SD
Simon Tate, Ph.D.
Director
PE
Patrick Enright
Director